ICD-10-CM code · FY2027
E78 Disorders of lipoprotein metabolism and other lipidemias
Header codeNot billable: use one of the 18 billable codes below
About E78
Go deeper into hyperlipidemia.
Ask about the latest evidence, the landmark trials or what guidelines recommend, with every study cited. No ads, no sponsored answers.
Coding notes for E78
Excludes1 Not coded here: never report these together with this code (use the code given instead).
Block E70-E88 notes (apply to every code in it)
Excludes1 Not coded here: never report these together with this code (use the code given instead).
Excludes2 Not part of this condition, but a patient can have both: report both codes when both apply.
- Ehlers-Danlos syndromes (Q79.6-)
Chapter 4 notes (apply to every code in it)
Note
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Codes under E78 23
- E78.0 Pure hypercholesterolemiaHeader
- E78.00 Pure hypercholesterolemia, unspecifiedBillable
- E78.01 Familial hypercholesterolemiaHeader
- E78.010 Homozygous familial hypercholesterolemia [HoFH]Billable
- E78.011 Heterozygous familial hypercholesterolemia [HeFH]Billable
- E78.019 Familial hypercholesterolemia, unspecifiedBillable
- E78.1 Pure hyperglyceridemiaBillable
- E78.2 Mixed hyperlipidemiaBillable
- E78.3 HyperchylomicronemiaBillable
- E78.4 Other hyperlipidemiaHeader
- E78.41 Elevated Lipoprotein(a)Billable
- E78.49 Other hyperlipidemiaBillable
- E78.5 Hyperlipidemia, unspecifiedBillable
- E78.6 Lipoprotein deficiencyBillable
- E78.7 Disorders of bile acid and cholesterol metabolismHeader
- E78.70 Disorder of bile acid and cholesterol metabolism, unspecifiedBillable
- E78.71 Barth syndromeBillable
- E78.72 Smith-Lemli-Opitz syndromeBillable
- E78.79 Other disorders of bile acid and cholesterol metabolismBillable
- E78.8 Other disorders of lipoprotein metabolismHeader
- E78.81 Lipoid dermatoarthritisBillable
- E78.89 Other lipoprotein metabolism disordersBillable
- E78.9 Disorder of lipoprotein metabolism, unspecifiedBillable
Other categories in E70-E88
- E70 Disorders of aromatic amino-acid metabolismHeader
- E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolismHeader
- E72 Other disorders of amino-acid metabolismHeader
- E73 Lactose intoleranceHeader
- E74 Other disorders of carbohydrate metabolismHeader
- E75 Disorders of sphingolipid metabolism and other lipid storage disordersHeader
- E76 Disorders of glycosaminoglycan metabolismHeader
- E77 Disorders of glycoprotein metabolismHeader
- E79 Disorders of purine and pyrimidine metabolismHeader
- E80 Disorders of porphyrin and bilirubin metabolismHeader
- E83 Disorders of mineral metabolismHeader
- E84 Cystic fibrosisHeader
- E85 AmyloidosisHeader
- E86 Volume depletionHeader
- E87 Other disorders of fluid, electrolyte and acid-base balanceHeader
- E88 Other and unspecified metabolic disordersHeader
Latest research on hyperlipidemia
- Statin use after but not before breast cancer diagnosis is associated with improved mortality in hormone receptor-positive early breast cancer
- Statins do not increase breast cancer risk in postmenopausal women
- Novel inhibitory antibody, MAR001, lowers triglycerides and remnant cholesterol in humans
- Obicetrapib and ezetimibe combination therapy lowers LDL cholesterol in high-risk patients
- Mirum: Ctexli reduces cholesterol metabolite build-up in patients with cerebrotendinous xanthomatosis
Landmark trials from 2MM Classics
2MM+
Read the research behind every diagnosis
2MM+ gives you every study summary in full, Classics downloads of the landmark trials, EvidencePulse and HypeCheck, and ad-free reading.
See 2MM+ plansICD-10-CM FY2027 code set, as published by the CDC National Center for Health Statistics (NCHS) and CMS, effective October 1, 2026 to September 30, 2027. Codes, titles and notes are shown as published. Check payer rules and the official guidelines before billing. This page is not medical advice.